OSR Health, Inc. (OSRH) News
Follow OSR Health, Inc. (OSRH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
OSR Health Board Authorizes Talks With Potential OSRK Acquirer
OSR Health’s board authorized management to engage with a potential acquirer of OSRK for a reverse takeover.
MNA | Nov 02, 2026, 04:05 PM UTC
M
Nasdaq Panel Denies OSR Health Continued Listing Request
Nasdaq's Hearings Panel denied OSR Health's request for continued listing on October 23, 2026, and determined to delist its securities after the company failed to meet the minimum bid price requirement. Trading had been
REGULATION | Oct 28, 2026, 01:33 PM UTC
L
OSRH - Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
OSRH - Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
EQUITY | Aug 27, 2026, 09:01 PM UTC
L
OSRH - OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
OSRH - OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
EQUITY | Aug 21, 2026, 03:46 PM UTC
M
OSR Health gets Nasdaq delisting determination; plans appeal
OSR Health (OSRH) receives a Nasdaq staff delisting determination and intends to request a Hearings Panel appeal, with no further details on the underlying compliance issue provided.
REGULATION | Aug 19, 2026, 07:45 PM UTC
L
OSRH - OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
OSRH - OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
EQUITY | Aug 19, 2026, 10:30 AM UTC
M
OSRH Announces Clinical Data For Cancer Vaccine
OSRH to publish clinical data for cancer vaccine
EQUITY | Aug 03, 2026, 01:02 PM UTC
H
OSRH: Loyalty CVR Program Won't Trigger Price Adjustment
OSRH loyalty program won't adjust price
EQUITY | Jul 31, 2026, 04:00 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC